Wednesday, October 21, 2026

4:30 PM - 5:15 PM

Plenary / Clinical Innovation & Patient Impact Breakout Room

---

Details

Australia has the scientific capability to be a global leader in regenerative therapies, yet translating discoveries into scalable, accessible patient treatments remains a significant challenge. Success requires more than breakthrough science; it demands coordinated collaboration between industry, researchers, clinicians, government, manufacturers, investors, and patients. This session explores how well-designed public–private partnerships can accelerate translation, strengthen sovereign manufacturing capability, reduce development risk, and create clearer pathways from laboratory discovery to clinical adoption. Drawing on lessons from across Australia's regenerative therapies ecosystem, including the SMART CRC, the panel will highlight how aligning public investment with industry demand can drive innovation, attract capital, build workforce capability, and ultimately deliver life-changing therapies to patients faster and at greater scale.

---

Speaker